HomeEMCURE ⢠NSE
add
Emcure Pharmaceuticals Ltd
Previous close
âı1,639.00
Day range
âı1,631.20 - âı1,688.00
Year range
âı983.00 - âı1,688.00
Market cap
318.81B INR
Avg Volume
305.63K
P/E ratio
36.63
Dividend yield
0.18%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 23.63B | 20.42% |
Operating expense | 10.46B | 14.28% |
Net income | 2.31B | 49.97% |
Net profit margin | 9.75 | 24.52% |
Earnings per share | 13.67 | 68.32% |
EBITDA | 4.37B | 32.22% |
Effective tax rate | 26.27% | â |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.12B | 120.34% |
Total assets | â | â |
Total liabilities | â | â |
Total equity | 48.84B | â |
Shares outstanding | 189.59M | â |
Price to book | 6.55 | â |
Return on assets | â | â |
Return on capital | 13.58% | â |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 2.31B | 49.97% |
Cash from operations | â | â |
Cash from investing | â | â |
Cash from financing | â | â |
Net change in cash | â | â |
Free cash flow | â | â |
About
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
Founded
Apr 16, 1981
Website
Employees
6,731
